Pulmatrix, Inc. is a clinical-stage biopharmaceutical company, which is focused on developing inhaled therapies to address serious pulmonary diseases and central nervous system (CNS) disorders using its patented inhaled small particles easily respira... Read more
Yahoo
CNBC
MarketWatch
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.